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Abstract
Multivariable Mendelian Randomisation (MVMR) is a form of instrumental variable analysis
which estimates the direct effect of multiple exposures on an outcome using genetic variants as
instruments. Mendelian Randomisation and MVMR are frequently conducted using two-sample
summary data where the association of the genetic variants with the exposures and outcome
are obtained from separate samples. If the genetic variants are only weakly associated with
the exposures either individually or conditionally, given the other exposures in the model, then
standard inverse variance weighting will yield biased estimates for the effect of each expos-
ure. Here we develop a two-sample conditional F-statistic to test whether the genetic variants
strongly predict each exposure conditional on the other exposures included in a MVMR model.
We show formally that this test is equivalent to the individual level data conditional F-statistic,
indicating that conventional rule-of-thumb critical values of F > 10, can be used to test for
weak instruments. We then demonstrate how reliable estimates of the causal effect of each
exposure on the outcome can be obtained in the presence of weak instruments and pleiotropy,
by re-purposing a commonly used heterogeneity Q-statistic as an estimating equation. Fur-
thermore, the minimised value of this Q-statistic yields an exact test for heterogeneity due to
pleiotropy. We illustrate our methods with an application to estimate the causal effect of blood
lipid fractions on age related macular degeneration.
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1 Introduction
Instrumental variables (IV) is a form of regression analysis which estimates the causal effect of an
exposure on an outcome in the presence of unobserved confounding. Mendelian randomisation (MR)
is a rapidly expanding application of the IV method in the field of epidemiology in which genetic
variants are used as instruments. If genetic variants - usually single nucleotide polymorphisms
(SNPs) - are available which reliably predict the exposure and are not associated with the outcome
through any other pathway, then they are valid IVs. These genetic variants can then be used
as instruments to obtain an estimate for the causal effect of a modifiable health exposure on a
disease outcome1,2. The results of such an analysis can inform the development of public health, or
even pharmaceutical, interventions. MR is often conducted with summary -level data on the SNP-
exposure and SNP-outcome associations obtained from genome-wide association studies (GWAS)
without the need to have individual level data on the genetic variants, exposure and outcome
available to the researcher conducting the MR study.
Multivariable Mendelian Randomisation (MVMR) is a recently developed extension of MR
that can be applied with either individual or summary level data to estimate the effect of multiple,
potentially related, exposures on an outcome3,4. The three core assumptions that define a set of
SNPs, G, as valid IV’s for the purpose of an MVMR analysis are;
IV1: G must be strongly associated with each exposure given the other exposures included in the
model;
IV2: G is independent of all confounders of any of the exposures and the outcome; and
IV3: G is independent of the outcome given all of the exposures.4.
These assumptions are illustrated in Fig 1. A violation of IV1 induces ‘weak instrument bias’ in
the resulting estimates5,6. In a conventional (univariable) MR analysis, the definition of instrument
strength is straightforward and unambiguous. Assumption IV1 can be tested with an F-statistic,
which tests the association between the SNP and the exposure. When univariable MR analysis
based on individual level data from a single sample, if the F-statistic is larger than the rule-of-
thumb value of 10 then the SNPs are said to be a ‘strong’ instrument. We can then reject the null
hypothesis that the instruments are weak in the sense that the bias of the MR estimate is equal to
or greater than 10% of the observational (or ordinary least squares, OLS) association.5,6
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In any MVMR analysis it is necessary that there are at least as many instruments as exposures
and that this F-statistic is large for each exposure included, however this is no longer sufficient; the
SNP’s used as IV’s also need to predict each exposure conditional on the other predicted exposures
included in the estimation. This additional condition ensures that there is sufficient variation in
association between the SNPs and each exposure, to avoid a problem of weak instrument bias
in the MVMR model. Unlike in univariable MR, in MVMR weak instrument bias can bias the
estimated effect of each exposure either towards or away from the null. This makes testing for
weak instruments in any MVMR estimation particularly important.
Figure 1: Assumptions for a MVMR analysis
DAG illustrating the assumptions required for MVMR. Dashed lines represent associations that
must not exist for the SNPs to be valid instruments for the set of exposures
With individual level data, weak instruments can be tested in MVMR using the Sanderson-
Windmeijer conditional F-statistic, denoted FSW
7,4. Under weak instruments FSW has the same
distribution as the conventional F-statistic and so can be compared to the same critical values5,6.
Therefore when testing for weak instruments, verifying that FSW is greater than the rule-of-thumb
of 10 means that we can reject the null hypothesis that the average bias of the MVMR estimates
is at least 10% of the bias of the equivalent multivariable OLS estimates.
When individual level data on the genetic variants, exposure and outcome are not available
two-sample MVMR can be conducted using summary data estimates of SNP-exposure and SNP-
outcome associations. In two-sample MR, weak instruments bias the causal estimates towards
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the null rather than the observational association8. In this paper we consider testing for weak
instruments and estimation in the presence of weak instruments in the summary-data MVMR
setting. Sanderson et al (2019) derived a Q statistic (Qxj ) to test for underidentification (i.e.
where the SNPs explain none of the variation in an exposure) in two-sample MVMR. We formally
show in this paper that a transformation of this statistic has the same distribution as FSW and
therefore can also be compared to standard weak instrument critical values, or rule-of-thumb of
F>10, to test for weak instruments in the two sample setting.
We then go on to consider horizontal pleiotropy in MVMR. Horizontal pleiotropy is a major
threat to the validity of an MR analysis. It occurs when the SNPs have an effect on the outcome
(either directly or through another exposure not included in the model) that is not via the exposure
of interest, as illustrated by the dashed arrow from G to Y in Fig 1. This violates assumption IV3
and can lead to biased estimates of the causal effect of each exposure on the outcome from an
MR analysis9. Horizontal pleiotropy can be either ’balanced’, where the pleiotropic effects of the
SNPs in the estimation are evenly distributed between having positive and negative effects on the
outcome and so have no overall directional effect, or ’unbalanced’ where on average these pleio-
tropic effects act in one direction on the outcome. IVW estimation and MVMR-IVW estimation
are robust to balanced pleiotropy when the instruments are strong. However this no longer holds
if the exposures are only weakly predicted by the SNPs. A number of methods currently exist
for univariable MR estimation that are robust to pleiotropy under different assumptions.10,11,12,13
MVMR can mitigate horizontal pleiotropy via known pleiotropic pathways through the inclusion
of multiple exposures, however limited methods are available for pleiotropy robust MVMR mod-
els4,14,15. Furthermore, in the presence of weak instruments standard tests are increasingly likely
to detect pleiotropy when in truth none is present. The major contribution of this paper is to
extend weak instrument and pleiotropy robust estimation to two sample MVMR with an arbitrary
number of exposures. Furthermore, we show that a heterogeneity statistic derived within this es-
timation procedure provides an exact test for the presence of pleiotropy in the presence of weak
instruments. The methods presented here therefore provide the statistical framework for accurate
and reliable MVMR model fitting, with potentially large numbers of exposures, in the presence of
weak instruments and pleiotropy.
We apply our methods to determine whether particular subsets of metabolites can be strongly
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predicted by 150 SNPs associated with at least one of 118 metabolites using data first presented
by Kettunen et al 201616 and estimate the causal effect of those traits on Age related macular
degeneration (AMD). The two-sample conditional F-statistic calculated for these data highlights
that it is not possible to strongly predict multiple metabolites from the same subgroup despite
each lipid fraction having a moderately high individual F-statistic and that any MVMR estimates
including these is likley to be biased. Any analyst naively applying MVMR methods to such data
without the correct diagnostic statistics to hand is in danger of generating poor quality results.
Finally we present an R package (’MVMR’) that can conduct MVMR-IVW estimation and
calculate all of the test statistics and estimators discussed in this paper.
2 A Test for Weak Instruments
Let X = (X1, X2, ..., XK) be a set of K exposure variables and let G be a set of L instruments




π11 π12 . . . π1L





πK1 πK2 . . . πKL

, (1)
where for example π32 represents the association between exposure 3 and SNP 2. Without loss of
generality, testing whether the instrument set G can explain variation in a single exposure, X1,
conditional on all other exposures (X2, ..., XK) is equivalent to testing whether model (2) below is
identified
X1 = δ01 + δ1X−1 + ε1 (2)
Xm = π0m +
L∑
j=1
πmjGj + εm, m = 2, ...,K (3)
Here: δ01 and each π0m are scalar parameters; δ1 is a K − 1 vector of parameters, and ε1 and εm
are random error terms. Collecting π2, ..., πK into a single (K − 1) × L matrix, define Π−1 as the
matrix Π minus its first row. This model considers only the exposures, and not the outcome, of the
main estimation of interest as we wish to test whether the instruments explain any variation in X1
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over and above the variation explained in all of the other exposures. If this model is overidentified
then the rank of Π−1 is strictly greater than K − (L− 1) and the instruments can strongly predict
X1 conditional on all other exposures included in the estimation.
In two sample summary data settings we do not directly observe exposures X1, ..., XK , only
estimates for the K×L SNP-exposure associations that define Π̂ the estimated value of Π obtained
through regression of each exposure on each SNP. However we can use these association estimates
to define an analogous formula to (2)
π̂1 = δ1Π̂−1 + v1















Where j represents an individual SNP and π1j and Π−1j represent column j of π1 and Π−1 respect-
ively. δ̃∗ is the K by 1 vector (−1 δ̃2 . . . δ̂K), and δ̃k is a consistent estimator for δk, for example
estimated through an inverse variance weighted least squares regression of π̂1 on Π̂−1. The matrix
ΣV,j defines the covariance of the estimated effects of snp j on each of the exposures:
ΣV,j =

σ21,j σ12,j · · · σ1K,j
σ12,j σ
2





σ1K,j σ2K,j · · · σ2K,j

(5)
If each π̂kj is obtained separately via univariable regressions with an intercept, then the error terms
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v̂kiv̂mi, k 6= m (6)
Where vk,i and vm,i are the residual error terms for univariable regressions of SNP i on exposures
k and m respectively. Under the null hypothesis that the instruments do not contain enough
information to predict both exposure variables, Qx1 will be asymptotically χ
2
L−1 distributed where
L is the number of SNPs in the estimation. Rejecting the null hypothesis indicates that the
SNPs can predict X1 conditional on X2. Dividing the Q-statistic described above by the number
of instruments, adjusted for the number of exposures, in the model gives a test statistic that is
equivalent to the one sample conditional F statistic FSW . Two-sample MVMR-IVW estimation is
asymptotically equivalent to individual level two-stage least squares estimation and therefore this
test statistic can be applied to test for weak instrument in two-sample MVMR in the same way as
the conditional F-statistic for individual level data.17
FTS,k =
Qxk
L− (K − 1)
∼
χ2(L−(K−1))
L− (K − 1)
(7)
Where Qxk is the expression given in equation 4.
Critical values
Comparing this statistic to standard critical values from the F-distribution provides a test for a
lack of identification. However, even if the genetic instruments explain some of the variation in
the exposure they could still be ‘weak’. In this case the estimates obtained from the MVMR
estimation could still be considerably biased. The one sample conditional F-statistic (FSW ) has
the same distribution as the Stock-Yogo weak instrument test6. Therefore we can apply its weak
instrument critical values to identify weak instrument bias for univariable and multivariable two-
sample MR5,6,7. The weak instrument critical values derived by Stock and Yogo (2005) for the
bias of the 2SLS estimator relative to the OLS estimator are derived under the definition that the
instruments are weak when the bias of the IV estimator relative to the OLS estimator is at least
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10%. The measure of relative bias used is the squared bias of the IV estimator (βIV ) relative to
the squared bias of the OLS estimator (βOLS). This is given by the equation;
B2 =
(Eβ̂IV − β)′ΣX(Eβ̂IV − β)
(Eβ̂OLS − β)′ΣX(Eβ̂OLS − β)
Where ΣX = plim
1
nX
′X and X here represents the n×K matrix of all of the exposures included
in the estimation, n is the sample size. Calculating the bias in this way standardises the exposures
X so they are orthogonal and have unit standard deviation. However it means that the bias of
the estimated effect of any particular exposure may differ from 10% and the bias of any particular
exposure could act in the opposite direction to the bias of the model as a whole. If FTS is larger
than the relevant Stock-Yogo critical value we can reject the null hypothesis that the exposure is
only weakly predicted by the instruments. These critical values have only been derived for models
including up to 30 instruments, therefore in Table 1 we provide critical values for a larger range of
instruments to test for a 5%, 10% or 20% relative bias. These critical values are often approximated
to a rule of thumb of F > 10 to test a null hypothesis that the bias is at least 10% of the bias
of the OLS estimator. The critical values given above also show that the rule of thumb of 10 is
slightly smaller than the true critical value for this test and would lead to the null hypothesis being
rejected more frequently. The two sample FTS statistic tests the bias of the model as a whole,
this means that the sign of the bias of an individual causal parameter may differ from that of the
model’s bias, which is averaged across all of its constituent parameters. It also indicates that some
weakly predicted exposures could be biased away from the null hypothesis.




kZ 5% 10% 20%
25 21.37 11.44 6.19
50 21.26 11.14 5.86
100 21.02 10.84 5.64
200 20.79 10.61 5.46
300 20.62 10.52 5.38
400 20.56 10.45 5.32
500 20.50 10.40 5.29
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3 Weak Instrument Robust Two-sample MVMR
Estimation in the presence of weak instruments
In the presence of weak instruments, standard inverse variance weighted estimation of the MVMR
mode, which we refer to as MVMR-IVW, is biased. The LIML estimator has previously been
proposed as an alternative estimator for individual-level MR as it is less biased when there are
many weak instruments18. In the two-sample summary data setting, Bowden and colleagues19 and
Zhao and colleagues20 show that weak instruments can be effectively mitigated through minim-
isation of an appropriate heterogeneity statistic using weights that account for the variance of the
SNP-exposure associations is analagous to one-sample LIML estimation. It gives results that are
substantially less biased than conventional regression based IVW estimates in the presence of a
non-zero causal effect. The weak instrument robust estimation proposed by Bowden and colleagues











over β. Where β is a vector of causal parameters (to be estimated), Γ̂j is the estimated effect of
SNP j on the outcome, π̂j is a vector of effects of SNP j on each exposure included in the estimation





Here, σ2y,j is the variance of the estimated effect of the SNPs on the outcome, and ΣV,j is the
variance-covariance matrix defined in equation (5). This is equivalent to minimisation of the QA
statistic to test for heterogeneity described in Sanderson et al 20194 extended to a model with
more than two exposures. We label estimates for β obtained in this manner as β̂Q. The standard
MVMR-IVW estimate is vunerable to weak instrument bias because instead of minimising QA in
(8) using the full weights defined in (9) it incorrectly assumes that σ2Aj = σ
2
yj . This ignores the
component of variation from β′Σjβ and is only valid if either all elements of β are zero or Σj is
negligable in comparison to σ2yj .
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Testing for pleiotropy in the presence of weak instruments
Horizontal pleiotropy - where genetic variants influence the outcome through multiple phenotypes
can lead to a violation of the IV assumptions if they are not included as exposures in the MVMR
estimation. Under the assumption that not all the SNPs included in the estimation have a pleio-
tropic effect on the outcome through the same pathway, this will lead to greater variation in the
estimated causal effect of the exposures on the outcome than would be expected by chance. This
excess heterogeneity can be reliably tested for using the minimised QA statistic. More formally if all
SNPs used in the MVMR analysis are valid instruments, in the sense that they identify a common
set of causal parameters β, we would expect the QA statistic in (6) evaluated at β = β̂Q to follow
a Chi-squared distribution with L-K degrees of freedom. Crucially, the test is exact in the sense
that it will achieve its nominal type I error rate, even in the presence of weak instruments21. The
standard Q-statistic used to generate the MVMR-IVW estimate by setting σ2A,j = σ
2
y,j , referred to
here as QIV W , will generally have an inflated type 1 error rate (i.e. will detect pleiotropy too often
when none is present) unless all β′Σjβ terms are negligible.
Estimation with pleiotropic and weak instruments
Estimation of β through minimisation of (8) will give estimates of the direct effect of each exposure
on the outcome that are robust to weak instruments. However, these estimates will still be biased
in the presence of pleiotropy. In order to account for heterogeneity due to pleiotropy, we extend
the estimation of β by adding a pleiotropy variance parameter τ2 to the multivariable Q estimation



























We refer to the causal estimates derived in this way as β̂Q,het. This is a extension of the method
described in Bowden et al 2018 for univariable MR to the MVMR setting.19 This method will
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account for balanced pleiotropy which biases the MVMR-IVW estimates further in the presence
of weak instruments by accounting for excess heterogeneity in the per SNP estimated effects that
is not related to the variance in the SNP-exposure associations or SNP-outcome associations. It
will not however account for directional pleiotropy where the pleiotropic effects of the SNPs on the
outcome all, or mostly, act in one direction to either increase or decrease the outcome. However, it
is possible to look at the individual contribution of each SNP to QA to identify the largest outliers.
If a small number of SNPs are observed to have a large effect on QA they can potentially be removed
as a sensitivity analysis and the MVMR model re-estimated without them.
Confidence intervals for estimated effects
Estimation of β and τ2 through minimisation of QA, does not provide readily available and reliable
standard errors. We therefore suggest that standard errors are obtained, and confidence intervals
calculated, through a Jackknife procedure.
We propose the use of Jackknife rather than a bootstrap as with a moderate number of SNPs
the repeated sampling in a bootstrap can lead to very weak instruments in any particular iteration
even when the model has relatively strong instruments as a whole. A jackknife procedure estimates
the model leaving out each SNP in turn and then calculates the standard deviation of the effect
estimate from these results. As each iteration includes all but one of the SNPs and includes each
SNP only once this is unlikely to be affected by weak instruments due to the exclusion of some SNPs.
When the number of SNPs used in the estimation is very small neither a Jackknife or bootstrap
approach will calculate appropriate standard errors however many applications of MVMR include
100 - 200 SNPs as instruments and with this number of SNPs a jackknife approach will be feasible.
4 Estimation of ΣV j
So far we have assumed that the pairwise covariance between a set of SNP’s estimated association
with any two exposures is known for all exposures and all SNPs. However, this data is not generally
reported by GWAS summary statistics. Similarly it would not be feasible for these studies to report
this data due to the large number of potential covariances that could be required for all potential
future MVMR analyses. Excluding these covariances will give the correct estimation only under
the global null (β = 0).
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Therefore, in this section we suggest three different solutions for dealing with the lack of co-
variances in the GWAS summary results in order to estimate σkm,j : the covariance between π̂k,j
and π̂m,j with respect to exposure, k, exposure, m (k 6= m) and SNP j which form the elements of
ΣV,j .
Estimate σkm,j from the individual level data If some or all of the individual level data that
was used in the GWAS to estimate the SNP - exposure associations is available then the covariances
for the effect of each SNP on each exposure can be calculated from equation 6.
Estimate the phenotypic correlation between the exposures from individual level data
The covariance for each SNP can then be approximated as;
σkm,j = ρkmσk,jσm,j (10)
where ρkm is the correlation between Xk and Xm (or phenotypic correlation). σkj and σmj are
the standard error for the effect of SNP j on exposures k and m respectively. Although ideally
this information would be calculated from the data used for the GWAS study, ρkm could also be
estimated from only part of the data used in the GWAS or from an alternative dataset which is
thought to have a similar structure.
Estimate the effect of the SNPs on each exposure from separate samples Estimating
the effect of the SNPs on each exposure in this manner means that the covariances will be zero
and so excluding this information will not affect the statistics calculated. For an MVMR analysis
involving K exposures, this would require K + 1 separate samples and so is likely to only be
practicable in a limited number of cases.
In any given scenario some of these solutions may be impossible (due to a lack of data) and
of the solutions that are possible, one may be the most reasonable. We suggest that estimation of
ρkm from phenotypic data, from which the appropriate covariances can then be calculated, is likely
to be the most feasible and appropriate approach in many cases.Under the assumption that each
SNP explains a small proportion of the variation in the exposure, the accuracy of the estimate of
σkm,j will depend on the accuracy of the estimate of ρkm. Therefore when ρkm is estimated from
data that does not closely match that used to estimate the SNP exposure associations exploration
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of how sensitive FTS and βQ,het are to that estimate should also be conducted. This could be
done through estimation of FTS and βQ,het at the limits of or across the range of reasonable values
of ρkm. These results should then be used to determine whether the interpretation of the results
changes over plausible values of ρkm.
5 Simulation Results
To illustrate the methods presented so far give here results from simulating and fitting MVMR
models with 200 SNPs and either 2 or 3 exposures.
MVMR model with two exposures
Firstly, we simulated a MVMR model with 2 exposures and 200 SNPs. The SNP-exposure associ-
ations where constructed in two ways; firstly so that each exposure was individually and condition-
ally weakly predicted by the set of SNPs (i.e. weak instruments) and secondly so that the exposures
were strongly individually predicted, but weakly conditionally predicted by the set of SNPs (i.e.
conditionally weak instruments). In each case the association of each SNP with the exposure was
drawn from a uniform distribution with the range of association selected to maintain the desired
overall instrument strength. All of the SNPs were associated with both exposures, for the weak
instruments there was no correlation between the association between each SNP and each exposure.
Conditionally weak instruments were generated by increasing the total strength of the instruments
but introducing correlation between the effect of each SNP on each of the exposures following the
structure of weak instrument asymptotics first introduced by Staiger and Stock (1997)5. This re-
flects a scenario where examination of standard F-statistics for each exposure would not identify
weak instruments. The exposures were simulated to both have a direct effect on the outcome and
balanced pleiotropy was introduced to the model through a direct effect of the SNPs on the out-
come. Pleiotropic effects were generated from a normal distribution with zero mean. A confounder
of both exposures and the outcome was also included. The covariance parameter σi,j , i 6= j was
estimated from calculation of the phenotypic correlation between X1 and X2 as described in section
4. The set up of this model is illustrated in Fig. 2 and results from the simulation are given in
Table 2. Results for the same model without the pleiotropic effect of the SNPs on the outcome are
given in Supplementary Table S.1.
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Results from this simulation show that the two-sample conditional F statistic FTS reliably es-
timates the strength of the instruments and is equivalent to the conditional F statistic calculated
from the individual level data FSW when the correlation between the exposures is used to estimate
the covariance between the effect of each SNP on each exposure. These results also show that
although β̂Q does not reliably estimate the effect of the exposure on the outcome in the presence
of balanced of pleiotropy, β̂Q,het which allows for this additional heterogeneity does. This decrease
in bias in β̂Q,het compared to β̂MVMR−IV W when the instruments are weak comes at the cost of
increased standard errors, reflecting the (true) lower level of information in the model. Supplement-
ary Table S.1 shows that allowing for heterogeneity when it is not present does not increase the
standard error of the β̂Q,het estimates relative to the standard error of the β̂Q estimate. Table 2 also
gives FTS and βQ,het estimated without accounting for σkm, labelled FTS,0 and β̂Q,het,0 respectively.
This imposes the assumption that σkm = 0, k 6= m, but not the assumption that σ2k = 0 and so
is a point between standard MVMR-IVW estimation and β̂Q,het. These results also show that in
the presence of conditionally weak instruments, when there is correlation between the effect of the
SNPs on each exposure, if these correlations are not taken into account FTS,0 does not reliably test
the strength of the instruments and β̂Q,het,0 produces biased estimates of the effect of each exposure
on the outcome.
Three exposure model
Next we simulated summary data for three exposures and 200 SNPs. Each of the exposures was
simulated to have a direct effect on the outcome. All of the SNPs included in the estimation are
associated with every exposure. The effect of the SNPs on the second exposure was uncorrelated
with the effects on the first or third exposures. However, the effect of the SNPs on the first and
third exposures were correlated, so that the third exposure was only weakly predicted by the SNPs
conditional on the first exposure (and therefore the first exposure is weakly predicted conditional on
the third exposure). This set up means that when only the first two exposures are included in the
estimation there is directional pleiotropy present, however when all three exposures are included
there is potential weak instrument bias. When the two exposures are included they each have
mean conditional F-statistics of 45 whereas in the model with three exposures included exposure
1 has a mean conditional F-statistic of 6.5 and exposure 3 has a mean conditional F-statistic 3.2.
14
Figure 2: Model simulated in Table 2
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Table 2: Simulation results for models with heterogen-
eity: two exposures, 200 SNPs
Weak instruments Conditionally
weak instruments
x1 x2 x1 x2
One-sample estimation with individual level data
β̂OLS 1.09 -0.049 0.78 -0.48
(0.033) (0.033) (0.029) (0.026)
β̂IV 0.585 -0.283 0.548 -0.333
(0.533) (0.533) (0.311) (0.226)
F 8.80 8.80 1602.81 3107.5
(0.61) (0.62) (107.67) (208.06)
FSW 3.40 3.40 9.75 9.78
(0.360) (0.360) (0.94) (0.95)
Two-sample estimation with covariances
β̂IV W 0.352 -0.128 0.469 -0.276
(0.541) (0.541) (0.316) (0.228)
β̂Q −7.7x103 6.7x103 −6.6x105 4.7x105
(1.2x105) (1.0x105) (2.3x106) (1.6x106)
β̂Q,het 0.487 -0.246 0.519 -0.313
(0.777) (0.778) (0.350) (0.253)
FTS 3.35 3.35 9.13 9.15
(0.348) (0.347) (0.814) (0.819)
Two-sample estimation without covariances
β̂IV W 0.352 -0.128 0.469 -0.276
(0.541) (0.541) (0.316) (0.228)
β̂Q −6.8x103 6.0x103 −6.0x105 4.3x105
(1.1x105) (9.5x104) (6.5x105) (4.8x105)
β̂Q,het 0.499 -0.260 −4.5x105 3.2x105
(0.802) (0.803) (1.5x106) (1.1x106)
FTS 3.17 3.17 0.45 0.45
(0.337) (0.336) (0.054) (0.054)
β1 = 0.5, β2 = −0.3
4,000 repetitions, 20,000 observations per repetition
Covariances estimated from the phenotypic correlation
between each exposure.
Weak instruments shows a scenario where the exposures are
individually weakly predicted by the SNPs. Conditionally
weak instruments gives a scenario where the exposures are
strongly predicted by the SNPs individually but are each
weakly predicted by the SNPs conditional on the other ex-
posure.
When three exposures are included in the model exposure 2 is still strongly predicted with a mean
conditional F-statistic of 17.9. The model under which the data was generated is illustrated in Fig.
16
3 and results are given in Table 3.
We give results from estimation of the model firstly including only two exposures, x1 and x2,
and including all three exposures. These results show that when only two exposures are included
in the model all methods of estimating β1 and β2 are biased by the directional pleiotropy present
in the model. When all three exposures are included in the model the MVMR-IVW estimates are
biased due to the presence of weak instruments. However, estimation of β̂Q through minimisation
of QA gives unbiased estimates of the effect of each exposure.
Figure 3: Model simulated in Table 3
 
Heterogeneity Testing
Table 4 gives the rejection rates when using QIV W and QA to test for pleiotropy for the model
considered in Figure 2. In addition, we show rejections rates using a third heterogeneity statistic




this heterogeneity statistic QIV W,up. These extended weights are calculated using a multivariable
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Table 3: Simulation results for a model with three exposures.
Two exposures Three exposures
included in estimation included in estimation
x1 x2 x1 x2 x3
One-sample estimation with individual level data
β̂OLS 0.837 -0.065 0.667 -0.176 1.418
(0.020) (0.019) (0.020) (0.018) (0.012)
β̂IV 0.626 -0.244 0.466 -0.314 0.912
(0.018) (0.018) (0.017) (0.014) (0.064)
F 236.2 235.13 236.22 235.13 14.50
(15.43) (13.67) (15.43) (13.67) (0.89)
FSW 78.49 78.37 6.62 19.81 3.17
(7.10) (6.98) (1.13) (5.38) (0.29)
Two-sample estimation with covariances
β̂IV W 0.611 -0.228 0.523 -0.277 0.502
(0.021) (0.021) (0.027) (0.021) (0.101)
β̂Q 0.626 -0.246 0.500 -0.301 0.703
(0.022) (0.021) (0.034) (0.024) (0.149)
β̂Q,het 0.624 -0.246 0.499 -0.301 0.705
(0.022) (0.021) (0.035) (0.024) (0.154)
FTS 45.01 44.97 6.58 17.94 3.23
(2.39) (2.35) (1.09) (4.32) (0.29)
β1 = 0.5, β2 = −0.3, β3 = 0.7
4,000 repetitions, 20,000 observations per repetition
Covariances estimated from the phenotypic correlation between each
exposure. Two exposures included in estimation refers to estimation of
the model including only exposures 1 and 2. Three exposures included
in estimation includes exposures 1, 2 and 3.
extension of the iterative estimation described in Bowden et al (2019).19 These results show that
when there is no heterogeneity the null hypothesis is over rejected by both QIV W and QIV W,up.
Although the iterative updating improves on standard estimation it does not fully correct for the
over rejection due to weak instruments.19 Estimation of QA using direct minimisation controls the
type 1 error and when the null hypothesis is true, i.e. when there is no heterogeneity this test
statistic rejects approximately 5% of the time.
6 Application
In this section we illustrate the use of the methods described above through an application to
the estimation of the effect of multiple metabolites to age-related macular degeneration (AMD).
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Table 4: Estimation of QA.
Weak instruments Conditionally
weak instruments
τ2 = 0 τ2 = 0.5 τ2 = 0 τ2 = 0.5
Estimate Rej. Rate Estimate Rej. Rate Estimate Rej. Rate Estimate Rej. Rate
QIV W 228.37 41.9% 13366.76 100% 249.71 75.4% 13032.82 100%
(23.04) (678.27) (24.85) (770.59)
QIV W,up 206.20 12.9% 11645.15 100% 201.36 7.6% 11593.22 100%
(21.39) (1699.61) (20.53) (1338.27)
QA 197.16 4.5% 576.93 100% 197.74 5.2% 1788.42 100%
(19.83) (53.92) (19.85) (224.66)
4,000 repetitions, 20,000 observations per repetition
Covariances estimated from the phenotypic correlation between each exposure.
AMD is disease that causes loss of central vision and is a leading cause of blindness22. Elevated
lipid serum levels have previously been associated with increased risk of AMD23. We use data
from a Genome-wide association study (GWAS) of 118 metabolites by Kettunen et al 201616 as
our exposure and from a GWAS of AMD as our outcome24. The GWAS data for our exposures
included 150 SNPs that were genome-wide signification for at least one of the metabolites. Previous
studies have implicated HDL as being causal for AMD25,26,27. In this analysis we illustrate the
issues with weak instrument bias that can arise from including multiple highly related traits in one
MVMR estimation.
The GWAS data included 118 potential metabolite exposures. For the purposes of illustration
we restricted the analysis to 14 metabolites moderately well predicted by a large number of SNPs.
Specifically we selected the 13 metabolites that had 42 or more SNPs with an F-statistic greater
than 5 associated with them in our data. From the 150 SNPs included in the data we retained
all SNPs which were associated with at least one of our selected exposures with an F statistic
greater than 5. This gave us 78 SNPs associated with our 13 metabolites for our analysis. From
this data we considered 6 different models to estimate and for each one obtained the MVMR-IVW
effect estimates and investigated whether the SNPs included as instruments could conditionally
predict the exposures in that model. The models considered were (a) all selected metabolites (b)
- (e) subgroups of metabolites grouped by lipid fraction type and (f) a subgroup including one
metabolite from each group included in (b) - (e).
Table 5 gives results for the estimation of model (a) including all of the selected metabolites.
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This table also reports; the mean individual F-statistic for the SNPs associated with each metabolite
(Find), the mean F-statistic across all of the SNPs included in the analysis for each metabolite
(Fall) and the conditional F-statistic for each metabolite (FTS). The correlation between the
metabolites, required to calculate FTS , was not available from the GWAS data used here. We
therefore calculated these using external data on the same metabolites from the Avon Longitudinal
Study of Mothers and Children (ALSPAC)28,29. A description of the ALSPAC study is given in
the supplementary material. The F-statistics and conditional F-statistics presented for the model
including all metabolites show that although each metabolite is strongly predicted by the SNPs
associated with it the conditional F-statistics for each exposure are very small and therefore the
effect estimates are subject to weak instrument bias.
Table 5: MVMR estimates of a range of metabolites on AMD, all metabolites included
in one MVMR estimation
Estimate Std. Error P-value F FTS
ApoB ApoB 1.673 0.693 0.019 10.82 0.197
IDL IDL.PL -4.456 0.969 <0.001 11.84 0.011
IDL.P 6.481 3.396 0.061 11.76 0.626
IDL.TG 0.437 1.391 0.754 11.04 0.003
LDL L.LDL.L -8.695 8.376 0.303 11.15 0.001
L.LDL.P 5.223 11.125 0.640 11.34 0.001
M.LDL.P 1.794 2.360 0.450 10.56 0.011
Small VLDL S.VLDL.PL 1.054 1.530 0.493 8.62 0.029
S.VLDL.C 1.346 1.617 0.408 8.88 0.005
S.VLDL.FC -1.270 1.331 0.343 8.75 0.019
Very Small VLDL XS.VLDL.L -6.655 1.982 0.001 10.67 0.027
XS.VLDL.P 4.866 1.668 0.005 10.19 0.048
XS.VLDL.TG -2.384 1.819 0.195 9.14 0.022
F is the mean F-statistic across all SNPs included in the estimation and is the univariable F-
statistic for instrument strength. FTS is the conditional F-statistic accounting for the association
between each SNP and all of the other exposures included in the estimation.
78 SNPs included in the estimation. ApoB is associated with 48 SNPs, IDL.PL, L.LDL.L,
L.LDL.p, M.LDL.P, S.VLDL.PL and XS.VLDL.L are each associated with 43 SNPs, IDL.P,
IDL.TG, S.VLDL.C, S.VLDL.FC, XS.VLDL.P adn XS.VLDL.TG are each associated with 42
SNPs.
Table 6 gives the same results for the estimation for each sub group of metabolites (IDL, LDL,
Small VLDL and Very Small VLDL). These results show that, with the exception of IDL.PL
and S.VLDL.PL, none of the metabolites are strongly conditionally predicted by the SNPs within
their subgroup. For our last analysis we included one metabolite from each group as exposures in
our MVMR estimation. Table 7 gives results for this set of exposures. Although the exposures
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here are jointly moderately strongly predicted by the set of SNPs the conditional F-statistics
for each exposures are still between 4.2 and 8.3 indicating that there is likely to be some weak
instrument bias. In Table 8 we re-estimate this final MVMR model using our weak instrument
robust estimators presented earlier. The results from this approach suggest that in our final model
the initial MVMR-IVW estimates may be biased towards the null due to weak instruments. QA for
this model is 118, the critical value at a 5% level of significance for a chi-squared distribution with
64 degrees of freedom is 84.7. It therefore indicates potential pleiotropy and we consider the β̂Q,het
to be the most appropriate estimates in this case. Comparison of these results to those obtained
from model (a) including all of the metabolites shows the potential for weak instruments to bias
results of a summary-data MVMR away from the null as well as towards the null. For 3 of the
4 metabolites included in both models the effect estimates in the final model are much closer to
zero than the results in the model including all of the metabolites. The results from this analysis
suggest that none of the metabolites considered are causally associated with AMD but that the
standard MVMR-IVW estimates for the final model were biased due to both weak instruments and
pleiotropic effects of the SNPs on the outcome. This null result is consistent with other results
using an alternative method to analyse the same data which found that HDL (not included in this
analysis) was the only metabolite that was causally associated with AMD27.
7 Software
We have written an R package MVMR which facilitates the implementation of MVMR estima-
tion and corresponding sensitivity analyses. The package requires summary data on instrument-
exposure and instrument-outcome associations, as well as information on the pairwise covariances
of the error in the estimated association between each SNP and each pair of exposures. As these
covariances are often not available the software can be implemented in three ways; estimating the
covariances from individual level data, approximating the covariances from the phenotypic correl-
ation between the exposures or assuming that these covariances are zero.
Workflow
Fitting and interpreting MVMR using the methods described in this paper, including tests for
instrument strength and horizontal pleiotropy, is performed using a five-step procedure. Initially,
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Table 6: MVMR estimates of a range of metabolites on AMD, estimated by subgroup
Estimate Std. Error P-value F FTS
ApoB ApoB
IDL; 54 SNPs
IDL.PL -1.338 1.091 0.226 16.05 1.23
IDL.P 1.864 1.231 0.134 16.12 1.24
IDL.TG -0.926 0.398 0.024 14.97 2.23
LDL; 46 SNPs
L.LDL.L 3.707 4.341 0.398 17.58 0.019
L.LDL.P -4.781 3.484 0.177 73.83 0.023
M.LDL.P 0.896 1.443 0.538 16.55 0.063
Small VLDL; 50 SNPs
S.VLDL.PL -0.513 1.021 0.617 12.38 11.65
S.VLDL.C -0.372 0.858 0.667 12.42 4.75
S.VLDL.FC 0.506 1.298 0.698 12.51 5.39
Very Small VLDL; 53 SNPs
XS.VLDL.L -1.651 1.863 0.380 14.64 0.174
XS.VLDL.P -0.105 0.533 0.845 12.50 0.916
XS.VLDL.TG 1.395 2.112 0.512 13.99 0.176
F is the mean F-statistic across all SNPs included in the estimation and is the univariable
F-statistic for instrument strength. FTS is the conditional F-statistic accounting for the
association between each SNP and all of the other exposures included in the estimation.
Table 7: MVMR-IVW estimates of a range of metabolites on
AMD including one exposure from each subgroup
Estimate Std. Error P-value F FTS
XS.VLDL.P -0.778 0.958 0.420 11.26 4.23
S.VLDL.PL 0.051 0.347 0.385 9.48 5.68
L.LDL.L 0.356 0.231 0.154 12.19 8.22
IDL.TG 0.067 0.761 0.969 12.21 6.15
69 SNPs
F is the mean F-statistic across all SNPs included in the estima-
tion and is the univariable F-statistic for instrument strength. FTS is
the conditional F-statistic accounting for the association between each
SNP and all of the other exposures included in the estimation.
summary data should be provided, including a covariance matrix for the effect of the genetic variants
on each exposure. As such covariances are not conventionally reported in publicly available data,
two functions snpcov_mvmr() and phenocov_mvmr() can be used to generate the covariance matrix.
The function snpcov_mvmr() estimates the covariance terms directly from individual level data,
whilst phenocov_mvmr() uses the phenotypic correlation and summary data (input by the user) to
generate estimates of the covariances.
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Table 8: Weak instrument robust estimates of a range of metabolites on AMD
including one exposure from each subgroup
β̂Q β̂Q,het
Est. Std. Error p-value Est. Std. Error p-value
XS.VLDL.P -5.008 3.774 0.185 -2.071 1.447 0.152
S.VLDL.PL 0.957 0.940 0.309 0.300 0.528 0.570
L.LDL.L 1.534 0.645 0.017 0.728 0.613 0.235
IDL.TG 2.490 2.614 0.341 0.803 1.437 0.576
69 SNPs
β̂Q gives the estimate obtained by minimisation of Q, β̂Q,het gives the estimate
obtained by minimisation of Q allowing for balanced pleiotropy.
As a second stage, the summary data is reformatted using the function format_mvmr() into
a data frame which is subsequently used as the input for estimation and sensitivity analyses.
We then provide the functions strength_mvmr() to evaluate instrument strength using the two
sample conditional F-statistic described in Section 2. Tests for horizontal pleiotropy are per-
formed using pleiotropy_mvmr(), performing both standard and Q-minimisation approaches
simultaneously (see section 3 for more details). Finally, causal effects can be estimated us-
ing two different approaches; fitting an inverse variance weighted (IVW) MVMR model using
ivw_mvmr()and minimising the Q-statistic allowing for heterogeneity using qhet_mvmr(). Each
step in the MVMR workflow is illustrated in Figure 4. The MVMR package is available to download
at https://github.com/WSpiller/MVMR/. The package also includes a detailed tutorial demon-
strating functionality of the package in an analyses of the effects of lipid fractions upon systolic
blood pressure using data from the Global Lipids Genetics Consortium and UK Biobank.
8 Discussion
In this paper we develop a general statistical framework for conducting two sample MVMR ana-
lyses for an arbitrary number of exposures in the presence of weak instrument bias and pleiotropy.
The methods presented here give ways to test for weak instruments in two-sample MVMR and
to robustly test for heterogeneity due to pleiotropy in the presence of moderately weak instru-
ments. We additionally give a method to estimate causal effects in the presence of moderately
weak instruments which is robust to balanced pleiotropy.
Weak instruments are a potential issue in many applications where estimating direct effects of
23
Figure 4: Workflow for MVMR R package
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multiple exposures using MVMR is preferred over univariable MR analyses , which are thought to be
likely to be affected by directional pleiotropy30,31,32,33,34. MVMR approaches are also used to gague
the extent to which one exposure mediates the effect of another on the outcome35,36.Any application
of MVMR will be biased by conditionally weak instruments and, as illustrated by our application,
this can occur even when the genetic variants strongly predict each exposure individually. Therefore,
the methods presented here are important as they provide a way to identify and correct for weak
instruments in two-sample MVMR estimation.
The FTS statistic described here is calculated using estimates of δ̂ calculated from an IVW
estimation of the effect of π̂−k on π̂k. An alternative method of estimation, equivalent to that
described for estimation of β, is to directly minimise its constituent Qxk to obtain LIML estimates
for δ 19,20. Whilst this procedure enacted on the QA statistic furnishes attractive, weak instrument
robust causal estimates, initial simulation results (not reported here) showed limited benefit of
estimating δ in this way therefore we did not investigate potential implementation further.
There are a number of limitations to this work. The test statistic and weak instrument robust
estimation requires an estimate of the covariance between the error in the estimated effect of each
SNP on each exposure. Our simulation results highlight how important this data can be as the
estimated values of FTS and β̂Q,het are changed so they become uninterpretable when this covariance
is fixed to zero. Although this data is generally not available we propose a method to estimate it,
using the phenotypic correlation between the exposures, which can be used to obtain a reasonable
approximation if the relevant covariance when each SNP only explains a small proportion of each
exposure. Where the data used to estimate the correlation between the exposures is the same
data used to estimate the SNP-exposure associations the estimated value of ΣV,j will closely match
the true value. When this is not the case the level of error in FTS and βQ,het that results from
misspecification of ρkm will depend on the other parameters in the model. For FTS this will depend
on how related the exposures are and how strongly (or weakly) they are predicted. Misspecification
of the conditional F-statistic will not matter if it is notably larger (or smaller) than 10 for all possible
values of ΣV,j as this will not change the interpretation of the results. For βQ,het how much the
specification of ΣV,j matters will depend on the estimated effect of each exposure, if all or all but
one of these are zero ΣV,j will not affect the estimated results, and the magnitude of any effect
will depend on the size of these estimated effects. When the data used for the estimation of ρkm
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does not match that used to obtain the SNP-exposure associations we have therefore proposed that
the researcher investigates how variation in ρkm affects the obtained values, and interpretation of
FTS and β̂Q,het. Where plausible variation in ρkm does affect the interpretation of the results this
limitation, and the resulting potential interpretations of the results obtained, should be accounted
for by the researcher applying this method.
Another weakness of the test statistics provided here is the lack of standard errors for the point
estimates of the direct effect of each exposure. We propose using a jackknife to estimate these
standard errors. This does however make the estimation of these statistic more computationally
intensive than would the case if the standard errors could be calculated analytically.
The weak instrument robust point estimates are robust to weak instruments but cannot produce
reliable estimates when instruments become very weak or if only a small number of SNPs are
available. Although we show this method works with moderately weak instruments it is not clear
exactly how weak is too weak, or indeed how few instruments are too few, to produce either reliable
point estimates or heterogeneity statistics. Gaining a more precise understanding of these questions
is a topic for further research.
Although we propose weak instrument robust estimation, if the weak instruments are limited to
only a small number of the exposures in the model an alternative approach may be to drop exposures
(one at a time) until the conditional F-statistics show that all of the exposures are strongly predicted
by the SNPs. This would however need to be considered carefully by the researcher. The model
to be estimated should not be decided purely by which exposures can be predicted but driven by
a research question of interest and dropping exposures has the potential to introduce directional
pleiotropy into the estimation biasing the resulting effect estimates. The choice of approach to
take would depend on the number of SNPs and exposures in the estimation and the relationship
between the exposures as well as how weak the SNPs are as instruments. As illustrated by our
application these approaches could be combined, excluding exposures until instrument strength is
high enough to reasonably apply the weak instrument robust methods. The choice approach needs
to be considered on a case by case basis.
Additionally although our final estimation βQ,het is robust to balanced pleiotropy it will still
give biased estimates in the presence of unbalanced or directional pleiotropy. Multivariable MR
Egger14, has been proposed as a method for obtaining reliable MVMR estimates in the presence
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of directional pleiotropy. Extending this approach to account for weak instrument bias is another
topic of further research.
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Box 1: Summary of statistics discussed in this paper.
Instrument strength statistics;
F - Measure of the strength of the instruments to predict one exposure. Applies to individual
or summary level data and to univariable or multivariable MR estimation.
Conditional F-statistic FSW - Measure of the strength of instruments to predict one exposure
conditional on the other exposures included in the estimation. Applies to multivariable MR
estimation with individual level data.
Conditional F-statistic FTS - Measure of the strength of instruments to predict one exposure
conditional on the other exposures included in the estimation. Applies to multivariable MR
estimation with summary data.
Qxj - A Q-statistic from which FTS is calculated.
Heterogeneity statistics;
QIV W - A heterogeneity test for MVMR that uses the IVW point estimates and does not
account for the uncertainty in the estimated SNP-exposure associations. This test over rejects
the null in the presence of weak instruments.
QIV W,up - A heterogeneity test for MVMR that uses the IVW point estimates but accounts
for the uncertainty in the estimated SNP-exposure associations. This test over rejects the null
in the presence of weak instruments, but to a lesser extent that QIV W .
QA - A heterogeneity test for MVMR that is robust to weak instruments, in the sense that it
has the appropriate type 1 error rate in the presence of weak instruments.
Estimation statistics;
β̂IV W - Estimates of the causal effect of each exposure on the outcome, estimated using stand-
ard inverse variance weighting.
β̂Q - Estimates of the causal effect of each exposure on the outcome, estimated through min-
imisation of QA. Robust to weak instruments.
β̂Q,het - Estimates of the causal effect of each exposure on the outcome, estimated through
minimisation of QA with an additional parameter to account for heterogeneity. Robust to
weak instruments and pleiotropy.
28
Box 2: Recommended tests in Two-sample MVMR.
In all two-sample summary data MVMR estimation two statistics should be calculated;
1. Conditional F statistics, FTS , for each exposure.
These test the strength of the genetic variants to predict each exposure in the multivari-
able mode. FTS < 10 suggests potential weak instrument bias in the MVMR estimation.
2. A Q-statistic for heterogeneity, QA, for the model.
Rejection of QA using standard significant levels (e.g. p < 0.05) indicates potential
pleiotropy in the form of excessive heterogeneity in the MVMR model. However, this
test will often reject in the presence of weak instruments.
If weak instruments are detected, i.e. any of the FTS values are less than 10, IVW MVMR es-
timates are potentially biased. When large numbers of SNPs are available this can be corrected
through;
3. Estimating β̂Q,het for each exposure
This method gives estimates of the direct effect of each exposure on the outcome that
are robust to (moderately) weak instruments.
4. An updated QA,min which minimises the Q statistic over βQ.
This test provides a test for heterogeneity that has the correct size in the presence of
weak instruments. Rejection of QA,min using standard significant levels (e.g. p < 0.05)
indicates potential pleiotropy in the MVMR model even in the presence of moderately
weak instruments.
All of these tests and estimation statistics are provided in the MVMR R package.
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